HAEMONETICS CORP - Common Stock (HAE) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
HAE on NYSE
Shares outstanding
47,898,935
Price per share
$80.15
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
51,316,369
Total reported value
$2,500,012,174
% of total 13F portfolios
0%
Share change
-2,935,220
Value change
-$235,189,883
Number of holders
295
Price from insider filings
$80.15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of HAEMONETICS CORP - Common Stock (HAE) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLINGTON MANAGEMENT GROUP LLP 4.6% -16% $137,687,404 -$30,316,086 2,203,351 -18% Wellington Management Group LLP 30 Jun 2025
T. Rowe Price Investment Management, Inc. 4.4% $130,131,375 2,195,569 T. Rowe Price Investment Management, Inc. 31 Mar 2025
Capital Research Global Investors 3.1% $93,487,934 1,577,323 Capital Research Global Investors 31 Mar 2025

As of 30 Sep 2025, 295 institutional investors reported holding 51,316,369 shares of HAEMONETICS CORP - Common Stock (HAE). This represents 107% of the company’s total 47,898,935 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of HAEMONETICS CORP - Common Stock (HAE) together control 76% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 13% 6,020,678 -5.4% 0.01% $293,447,860
VANGUARD GROUP INC 10% 4,834,646 -2.4% 0% $235,640,646
NEUBERGER BERMAN GROUP LLC 7.7% 3,670,282 -14% 0.13% $178,870,818
AQR CAPITAL MANAGEMENT LLC 4.4% 2,128,878 +373% 0.07% $102,814,162
STATE STREET CORP 3.8% 1,800,729 -4.4% 0% $87,767,531
River Road Asset Management, LLC 3.5% 1,654,790 -0.05% 0.9% $80,654,465
UBS Group AG 3% 1,452,571 +67% 0.01% $70,798,310
ROYAL BANK OF CANADA 2.6% 1,260,820 +16% 0.01% $61,451,000
FMR LLC 2.5% 1,215,829 +45% 0% $59,259,529
GEODE CAPITAL MANAGEMENT, LLC 2.5% 1,203,380 -3.3% 0% $58,660,306
DIMENSIONAL FUND ADVISORS LP 2.3% 1,099,519 +2.5% 0.01% $53,587,050
Allspring Global Investments Holdings, LLC 2.2% 1,060,790 +12% 0.08% $51,777,160
T. Rowe Price Investment Management, Inc. 2.1% 1,010,957 -37% 0.03% $49,275,000
Boston Trust Walden Corp 2% 956,690 -12% 0.34% $46,629,071
MILLENNIUM MANAGEMENT LLC 1.6% 773,179 +1957% 0.03% $37,684,744
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 1.5% 706,312 +36% 0.19% $34,425,647
ROYCE & ASSOCIATES LP 1.5% 701,242 -45% 0.34% $34,178,535
Fisher Asset Management, LLC 1.4% 662,504 -3.9% 0.01% $32,290,444
SILVERCREST ASSET MANAGEMENT GROUP LLC 1.3% 641,622 +7.2% 0.21% $31,272,775
FRANKLIN RESOURCES INC 1.3% 627,231 +2% 0.01% $30,571,250
NORTHERN TRUST CORP 1.3% 602,378 -5.2% 0% $29,359,903
GOLDMAN SACHS GROUP INC 1.2% 582,754 -9.6% 0% $28,403,430
Boston Partners 1.2% 570,891 +5.1% 0.03% $28,016,562
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.2% 561,812 -0.06% 0% $27,382,717
BARROW HANLEY MEWHINNEY & STRAUSS LLC 1.2% 559,972 +16% 0.09% $27,293,035

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,970,137 $157,761,603 -$17,871,138 $80.15 22
2025 Q3 51,316,369 $2,500,012,174 -$235,189,883 $48.74 295
2025 Q2 54,253,774 $4,048,407,950 +$51,089,019 $74.61 297
2025 Q1 53,717,229 $3,412,451,230 -$212,763,134 $63.55 312
2024 Q4 56,557,356 $4,415,632,776 +$78,519,415 $78.08 304
2024 Q3 55,369,327 $4,447,318,557 -$61,796,637 $80.38 303
2024 Q2 55,846,033 $4,620,823,885 +$424,655,139 $82.73 314
2024 Q1 50,702,920 $4,327,234,538 +$21,150,132 $85.35 295
2023 Q4 3,610,409 $308,765,970 -$2,966,841 $85.51 3
2023 Q3 50,035,829 $4,483,650,819 +$16,658,025 $89.58 292
2023 Q2 49,829,188 $4,242,821,609 -$31,046,722 $85.14 286
2023 Q1 49,838,065 $4,123,755,754 +$10,720,575 $82.75 293
2022 Q4 50,361,878 $3,961,626,712 -$105,864,488 $78.65 285
2022 Q3 51,170,611 $3,788,844,813 -$10,995,011 $74.03 254
2022 Q2 51,830,298 $3,371,541,193 +$47,593,765 $65.18 226
2022 Q1 51,229,994 $3,236,540,910 +$121,593,942 $63.22 222
2021 Q4 50,071,494 $2,654,975,021 -$88,986,284 $53.04 238
2021 Q3 50,729,161 $3,578,385,438 -$462,168 $70.59 243
2021 Q2 50,697,727 $3,376,743,272 -$104,591,659 $66.64 253
2021 Q1 46,728,366 $5,190,913,237 -$31,291,817 $111.01 284
2020 Q4 46,549,237 $5,528,500,932 +$22,152,409 $118.75 270
2020 Q3 46,415,336 $4,050,396,230 +$9,976,496 $87.25 256
2020 Q2 49,360,970 $4,423,099,650 -$131,302,989 $89.56 273
2020 Q1 50,512,391 $5,031,945,644 +$58,361,763 $99.66 260
2019 Q4 49,844,915 $5,726,883,199 -$8,425,406 $114.90 290
2019 Q3 49,617,874 $6,258,106,643 -$157,380,306 $126.14 271
2019 Q2 50,895,662 $6,123,921,590 +$154,989,187 $120.34 252
2019 Q1 51,283,498 $4,486,016,605 +$59,010,778 $87.48 253
2018 Q4 50,443,353 $5,047,273,313 -$149,981,910 $100.05 276
2018 Q3 51,715,308 $5,924,362,043 +$210,878,544 $114.58 289
2018 Q2 50,361,138 $4,516,582,617 -$95,989,189 $89.68 285
2018 Q1 52,543,455 $3,844,287,644 +$18,896,608 $73.16 253
2017 Q4 53,612,204 $3,114,333,238 -$26,064,067 $58.08 237
2017 Q3 54,747,260 $2,456,329,091 -$29,425,399 $44.87 201
2017 Q2 54,815,549 $2,164,682,845 +$24,941,264 $39.49 189
2017 Q1 54,634,240 $2,216,609,714 +$337,125,539 $40.57 174
2016 Q4 52,450,318 $2,108,491,648 +$26,281,918 $40.20 190
2016 Q3 51,093,313 $1,849,483,739 +$9,556,005 $36.21 171
2016 Q2 48,242,118 $1,398,894,581 -$26,986,730 $28.99 167
2016 Q1 51,159,189 $1,788,674,985 +$9,492,148 $34.98 157
2015 Q4 51,100,303 $1,647,406,369 -$35,199,383 $32.24 156
2015 Q3 52,121,290 $1,684,551,056 -$45,268,030 $32.32 167
2015 Q2 52,837,126 $2,185,319,190 -$10,644,581 $41.36 174
2015 Q1 53,751,288 $2,413,804,087 -$14,776,228 $44.92 167
2014 Q4 54,161,848 $2,026,670,717 +$23,064,733 $37.42 170
2014 Q3 52,079,379 $1,818,623,493 -$47,792,694 $34.92 166
2014 Q2 54,462,831 $1,921,442,064 +$20,397,287 $35.28 172
2014 Q1 54,173,562 $1,765,475,443 -$102,774,513 $32.59 187